BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 3 filers reported holding BIONTECH SE in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $448,575 | -8.9% | 4,129 | -9.5% | 0.00% | -66.7% |
| Q2 2023 | $492,269 | -29.8% | 4,561 | -18.9% | 0.00% | +200.0% |
| Q1 2023 | $700,831 | -21.7% | 5,626 | -5.6% | 0.00% | -50.0% |
| Q4 2022 | $895,612 | +18.5% | 5,962 | +6.4% | 0.00% | 0.0% |
| Q3 2022 | $756,000 | -25.4% | 5,602 | -17.5% | 0.00% | -33.3% |
| Q2 2022 | $1,013,000 | -11.1% | 6,793 | +1.8% | 0.00% | +50.0% |
| Q1 2022 | $1,139,000 | -21.8% | 6,676 | +18.1% | 0.00% | -33.3% |
| Q4 2021 | $1,457,000 | -83.6% | 5,653 | -82.6% | 0.00% | -86.4% |
| Q3 2021 | $8,876,000 | +138.2% | 32,515 | +95.3% | 0.02% | +120.0% |
| Q2 2021 | $3,727,000 | +118.0% | 16,646 | +6.3% | 0.01% | +66.7% |
| Q1 2021 | $1,710,000 | +26.6% | 15,661 | -5.5% | 0.01% | +50.0% |
| Q4 2020 | $1,351,000 | +31.7% | 16,577 | +11.8% | 0.00% | 0.0% |
| Q3 2020 | $1,026,000 | +50.7% | 14,827 | +45.4% | 0.00% | +33.3% |
| Q2 2020 | $681,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
| Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
| Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
| Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
| Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
| Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
| Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
| Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
| Robbins Farley | 13,220 | $2,255,000 | 1.70% |
| APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |